Business · 05/09/2024Updated: 10/17/2026 · 1 min read
FDA Announces Public Comment Period for Proposed Drug Registration and Listing Information Collection
Summary
The Food and Drug Administration is seeking public comment on its proposed collection of information related to drug establishment registration and listing requirements under the Federal Food, Drug, and Cosmetic Act, as mandated by the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →